Stocks and InvestingStocks and Investing
Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023

Alec Stranahan Maintained (YMAB) at Hold and Held Target at $6 on, Apr 1st, 2023


Published on 2024-10-28 02:31:59 - WOPRAI, Alec Stranahan
  Print publication without navigation


Alec Stranahan of B of A Securities, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Hold and Held Target at $6 on, Apr 1st, 2023.

Alec has made no other calls on YMAB in the last 4 months.



There are 4 other peers that have a rating on YMAB. Out of the 4 peers that are also analyzing YMAB, 1 agrees with Alec's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Thome of "Cowen & Co." Downgraded from Buy to Hold on, Thursday, January 5th, 2023


These are the ratings of the 3 analyists that currently disagree with Alec


  • William Maughan of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $18 on, Friday, March 31st, 2023
  • Etzer Darout of "BMO Capital" Maintained at Buy with Increased Target to $13 on, Monday, January 30th, 2023
  • Michael Ulz of "Morgan Stanley" Downgraded from Hold to Sell on, Friday, January 27th, 2023